Choosing therapy on the basis of disease classifications in inflammatory bowel disease

Maria T. Abreu

doi:10.1007/s11938-004-0038-9

Choosing therapy on the basis of disease classifications in inflammatory bowel disease

Maria T. Abreu

Research output: Contribution to journal › Review article › peer-review

Abstract

Crohn's disease and ulcerative colitis (UC) are heterogeneous disorders, and as such, the response to therapy is likewise heterogeneous. Therefore, stratification of patients into distinct phenotypes and potentially genotypes will lead to more definitive answers with respect to evaluation of novel and established therapies.

Original language	English
Pages (from-to)	169-179
Number of pages	11
Journal	Current Treatment Options in Gastroenterology
Volume	7
Issue number	3
DOIs	https://doi.org/10.1007/s11938-004-0038-9
State	Published - Jun 2004
Externally published	Yes

Access to Document

10.1007/s11938-004-0038-9

Cite this

@article{e757bf24428b40afba3e1ae63096e09b,

title = "Choosing therapy on the basis of disease classifications in inflammatory bowel disease",

abstract = "Crohn's disease and ulcerative colitis (UC) are heterogeneous disorders, and as such, the response to therapy is likewise heterogeneous. Therefore, stratification of patients into distinct phenotypes and potentially genotypes will lead to more definitive answers with respect to evaluation of novel and established therapies.",

author = "Abreu, {Maria T.}",

year = "2004",

month = jun,

doi = "10.1007/s11938-004-0038-9",

language = "English",

volume = "7",

pages = "169--179",

journal = "Current Treatment Options in Gastroenterology",

issn = "1092-8472",

publisher = "Current Science, Inc.",

number = "3",

}

TY - JOUR

T1 - Choosing therapy on the basis of disease classifications in inflammatory bowel disease

AU - Abreu, Maria T.

PY - 2004/6

Y1 - 2004/6

N2 - Crohn's disease and ulcerative colitis (UC) are heterogeneous disorders, and as such, the response to therapy is likewise heterogeneous. Therefore, stratification of patients into distinct phenotypes and potentially genotypes will lead to more definitive answers with respect to evaluation of novel and established therapies.

AB - Crohn's disease and ulcerative colitis (UC) are heterogeneous disorders, and as such, the response to therapy is likewise heterogeneous. Therefore, stratification of patients into distinct phenotypes and potentially genotypes will lead to more definitive answers with respect to evaluation of novel and established therapies.

UR - http://www.scopus.com/inward/record.url?scp=3142621222&partnerID=8YFLogxK

U2 - 10.1007/s11938-004-0038-9

DO - 10.1007/s11938-004-0038-9

M3 - Review article

AN - SCOPUS:3142621222

SN - 1092-8472

VL - 7

SP - 169

EP - 179

JO - Current Treatment Options in Gastroenterology

JF - Current Treatment Options in Gastroenterology

IS - 3

ER -

Choosing therapy on the basis of disease classifications in inflammatory bowel disease

Abstract

Access to Document

Fingerprint

Cite this